CYTYC Message Board - Msg: 1107001

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTYC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richard luis who wrote (64)	4/1/1997 11:03:00 PM
From: John Zwiener	of 79

Luis, a few comments. A cytotechnologist can screen up to 80 slides a day and rescreen (for quality control) up to 40. So for all practical purposes, they screen 80 slides. As for reimbursement, the third party payers (private and government) are definitely beginning to pay for the increased cost. The instrument can process 20-25 samples per hour, but still have to be screened. But the slide produced is of higher quality so the screening is more sensitive and accurate (60% higher rate of detection with fewer unsatisfactory). The apparent alliance with neopath is great. The two processes together pick up 95% of low grade and 100% of high grade lesions. Apparently, neopath is fine tuning their automated screening instrument to pick up even more of the low grade lesions. If one can get past the wild price swings, cytyc and npth should do very well.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next